# SRX Global Inc.: overview

SRXH · NYSE · CIK 1471727 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/srxh.md) · [Financials](/companies/srxh/financials.md) · [Filings](/companies/srxh/filings.md) · [Insiders](/companies/srxh/insiders.md)

Latest reported revenue: [$3.4m](/filings/0001493152-26-037793.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-037793).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.4](/filings/0001493152-24-045248.md) | [7.2 d](/filings/0001641172-25-001558.md) | [7.2](/filings/0001641172-25-011011.md) | [2.7](/filings/0001493152-26-037793.md) | [3.9 d](/filings/0001493152-25-026452.md) | [2.8](/filings/0001493152-26-006816.md) | [3.4](/filings/0001493152-26-023072.md) | [3.4](/filings/0001493152-26-037793.md) |
| Gross margin | % | [39.7%](/filings/0001493152-24-045248.md) | [36.4% d](/filings/0001641172-25-001558.md) | [33.3%](/filings/0001641172-25-011011.md) | [1.2%](/filings/0001493152-26-037793.md) | [38.7% d](/filings/0001493152-25-026452.md) | [37.5%](/filings/0001493152-26-006816.md) | [37.1%](/filings/0001493152-26-023072.md) | [26.7%](/filings/0001493152-26-037793.md) |
| Operating margin | % | [(9.9%)](/filings/0001493152-24-045248.md) | [(23.0%) d](/filings/0001641172-25-001558.md) | [(15.2%)](/filings/0001641172-25-011011.md) | [(322.0%)](/filings/0001493152-26-037793.md) | [(72.5%) d](/filings/0001493152-25-026452.md) | [(135.0%)](/filings/0001493152-26-006816.md) | [(52.9%)](/filings/0001493152-26-023072.md) | [(94.4%)](/filings/0001493152-26-037793.md) |
| Net margin | % | [13.4%](/filings/0001493152-24-045248.md) | [(55.6%) d](/filings/0001493152-26-037793.md) | [(141.8%)](/filings/0001493152-26-037793.md) | [(566.1%)](/filings/0001493152-26-037793.md) | [(395.3%) d](/filings/0001493152-25-026452.md) | [(306.9%)](/filings/0001493152-26-037793.md) | [(185.5%)](/filings/0001493152-26-037793.md) | [(122.1%)](/filings/0001493152-26-037793.md) |
| Diluted EPS | $ per share | [0.73](/filings/0001493152-24-045248.md) | [(0.17)](/filings/0001493152-26-006816.md) | [(0.39)](/filings/0001493152-26-023072.md) | [(44.51)](/filings/0001493152-26-037793.md) | not reported | [(0.26)](/filings/0001493152-26-006816.md) | [(0.02)](/filings/0001493152-26-023072.md) | [(0.36)](/filings/0001493152-26-037793.md) |
| Free cash flow | $m | [(2.1) d](/filings/0001493152-25-026452.md) | [1.5 d](/filings/0001493152-26-006816.md) | [0.4](/filings/0001641172-25-011011.md) | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 9-month figure less the 6-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-09-30) | FY2024 (2024-12-31) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [54.7](/filings/0001493152-24-014436.md) | [38.6](/filings/0001641172-25-001558.md) | not reported | [35.0](/filings/0001641172-25-001558.md) | [6.5](/filings/0001493152-25-026452.md) |
| Gross margin | % | [27.9%](/filings/0001493152-24-014436.md) | [30.6%](/filings/0001641172-25-001558.md) | not reported | [37.1%](/filings/0001641172-25-001558.md) | [23.4%](/filings/0001493152-25-026452.md) |
| Operating margin | % | [(71.0%)](/filings/0001493152-24-014436.md) | [(54.9%)](/filings/0001641172-25-001558.md) | not reported | [(17.1%)](/filings/0001641172-25-001558.md) | [(174.6%)](/filings/0001493152-25-026452.md) |
| Net margin | % | [(71.9%)](/filings/0001493152-24-014436.md) | [(59.0%)](/filings/0001641172-25-001558.md) | not reported | [(0.5%)](/filings/0001641172-25-001558.md) | [(688.8%)](/filings/0001493152-25-026452.md) |
| Diluted EPS | $ per share | [(58.93)](/filings/0001493152-24-014436.md) | [(32.29)](/filings/0001641172-25-001558.md) | [(1.95)](/filings/0001493152-25-026452.md) | [(0.10)](/filings/0001641172-25-001558.md) | [(2.13)](/filings/0001493152-25-026452.md) |
| Free cash flow | $m | [(20.8)](/filings/0001493152-24-014436.md) | [0.1](/filings/0001641172-25-001558.md) | not reported | [(4.4)](/filings/0001641172-25-001558.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/srxh/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $5.1k | 56,584 |  | New +56,584 |
| [Bogart Wealth, LLC](/funds/1715740.md) | 2026-06-30 | $907 | 10,000 |  | New +10,000 |
| [Cloud Capital Management, LLC](/funds/2060492.md) | 2026-06-30 | $0 | 20,000 |  | New +20,000 |

## Recent filings

[All 564 filings](/companies/srxh/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 12:05 ET | [8-K](/filings/0001493152-26-046085.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-046085 |
| 2026-10-06 | 20:05 ET | [8-K](/filings/0001493152-26-045941.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045941 |
| 2026-09-09 | 19:00 ET | [8-K](/filings/0001493152-26-041945.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041945 |
| 2026-09-02 | 20:47 ET | [8-K](/filings/0001493152-26-041250.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041250 |
| 2026-08-28 | 21:02 ET | [8-K](/filings/0001493152-26-040642.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-040642 |
| 2026-08-19 | 15:50 ET | [8-K](/filings/0001493152-26-039162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-039162 |
| 2026-08-13 | 20:20 ET | [10-Q](/filings/0001493152-26-037793.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037793 |
| 2026-07-29 | 16:04 ET | [8-K/A](/filings/0001493152-26-035136.md) | 3.02 Unregistered sale of equity | 0001493152-26-035136 |
| 2026-07-28 | 13:57 ET | [8-K](/filings/0001493152-26-034950.md) | 3.02 Unregistered sale of equity | 0001493152-26-034950 |
| 2026-07-21 | 20:07 ET | [8-K](/filings/0001493152-26-034081.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-034081 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001493152-25-026452.md), filed Dec 5, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8e63699e-fef1-4925-b550-656a45685223)

## About the filer

- CIK: 1471727
- Tickers: SRXH
- Exchange: NYSE
- SIC code: 2080 Beverages
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.
